Targeting the epithelial-to-mesenchymal transition: The case for differentiation-based therapy

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 81, Issue 1, 2016, Pages 11-19

  Pattabiraman, Diwakar R ^a   Weinberg, Robert A ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASEMENT MEMBRANE; BREAST CANCER; CANCER THERAPY; CARCINOMA CELL; CELL DIFFERENTIATION; CELL JUNCTION; CELL MIGRATION; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; LEUKEMIA; MALIGNANT TRANSFORMATION; MESENCHYME CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STEM CELL; TUMOR GROWTH; ANIMAL; CANCER STEM CELL; CELL TRANSFORMATION; CYTOLOGY; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; LEUKEMIA; NEOPLASMS; NEOPLASTIC STEM CELLS;

EID: 85021034956     PISSN: 00917451     EISSN: 19434456     Source Type: Book Series    
DOI: 10.1101/sqb.2016.81.030957     Document Type: Article

References (90)

1. Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M, Mikulits W, Brabletz T, Strand D, Obrist P, et al. 2007. The transcription factor ZEB1 (dEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 26: 6979-6988
2. Andriani F, Bertolini G, Facchinetti F, Baldoli E, Moro M, Casalini P, Caserini R, Milione M, Leone G, Pelosi G, et al. 2016. Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells. Mol Oncol 10: 253-271
3. Aranda V, Haire T, Nolan ME, Calarco JP, Rosenberg AZ, Fawcett JP, Pawson T, Muthuswamy SK. 2006. Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. Nat Cell Biol 8: 1235-1245
4. Barsky SH, Siegal GP, Jannotta F, Liotta LA. 1983. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 49: 140-147
5. Bednarz-Knoll N, Alix-Panabieres C, Pantel K. 2012. Plasticity of disseminating cancer cells in patients with epithelial malignancies. Cancer Metastasis Rev 31: 673-687
6. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A. 2003. The transcription factor Slug represses Ecadherin expression and induces epithelial to mesenchymal transitions: A comparison with Snail and E47 repressors. J Cell Sci 116: 499-511
7. Bonnomet A, Syne L, Brysse A, Feyereisen E, Thompson EW, Noel A, Foidart JM, Birembaut P, Polette M, Gilles C. 2012. A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer. Oncogene 31: 3741-3753
8. Bornholdt J, Friis S, Godiksen S, Poulsen SS, Santoni-Rugiu E, Bisgaard HC, Lothe IM, Ikdahl T, Tveit KM, Johnson E, et al. 2011. The level of claudin-7 is reduced as an early event in colorectal carcinogenesis. BMC Cancer 11: 65
9. Bronsert P, Enderle-Ammour K, Bader M, Timme S, Kuehs M, Csanadi A, Kayser G, Kohler I, Bausch D, Hoeppner J, et al. 2014. Cancer cell invasion and EMT marker expression: A three-dimensional study of the human cancer-host interface. J Pathol 234: 410-422
10. Cavallaro U, Christofori G. 2004. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4: 118-132
11. Celia-Terrassa T, Meca-Cortes O, Mateo F, Martinez de Paz A, Rubio N, Arnal-Estape A, Ell BJ, Bermudo R, Diaz A, Guerra-Rebollo M, et al. 2012. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J Clin Invest 122: 1849-1868
12. Chang CC, Hsu WH, Wang CC, Chou CH, Kuo MY, Lin BR, Chen ST, Tai SK, Kuo ML, Yang MH. 2013. Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells. Cancer Res 73: 4147-4157
13. Cheung KJ, Padmanaban V, Silvestri V, Schipper K, Cohen JD, Fairchild AN, Gorin MA, Verdone JE, Pienta KJ, Bader JS, et al. 2016. Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters. Proc Natl Acad Sci 113: E854-E 863
14. Clark AG, Vignjevic DM. 2015. Modes of cancer cell invasion and the role of the microenvironment. Curr Opin Cell Biol 36: 13-22
15. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F. 2001. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7: 1267-1278
16. De Arcangelis A, Hamade H, Alpy F, Normand S, Bruyere E, Lefebvre O, Mechine-Neuville A, Siebert S, Pfister V, Lepage P, et al. 2016. Hemidesmosome integrity protects the colon against colitis and colorectal cancer. Gut. doi: 10.1136/gutjnl-2015-310847
17. De Craene B, Berx G. 2013. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13: 97-110
18. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M, Berx G, Cano A, Beug H, Foisner R. 2005. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24: 2375-2385
19. Fan F, Samuel S, Evans KW, Lu J, Xia L, Zhou Y, Sceusi E, Tozzi F, Ye XC, Mani SA, et al. 2012. Overexpression of snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells. Cancer Med 1: 5-16
20. Fidler IJ. 2003. The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458
21. Fischer KR, Durrans A, Lee S, Sheng J, Li F,Wong ST, Choi H, El Rayes T, Ryu S, Troeger J, et al. 2015. Epithelial-tomesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527: 472-476
22. Friedl P, Gilmour D. 2009. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 10: 445-457
23. Friedl P, Locker J, Sahai E, Segall JE. 2012. Classifying collective cancer cell invasion. Nat Cell Biol 14: 777-783
24. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier W. 1991. E-cadherin-mediated cellcell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185
25. Greenburg G, Hay ED. 1982. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol 95: 333-339
26. Grigore AD, Jolly MK, Jia D, Farach-Carson MC, Levine H. 2016. Tumor budding: The name is EMT. Partial EMT. J Clin Med 5: 51
27. Grosse-Wilde A, Fouquier d'Herouel A, McIntosh E, Ertaylan G, Skupin A, Kuestner RE, del Sol A, Walters KA, Huang S. 2015. Stemness of the hybrid epithelial/mesenchymal state in breast cancer and its association with poor survival. PLoS One 10: e 0126522
28. Guo W, Keckesova Z, Donaher JL, Shibue T, Tischler V, Reinhardt F, Itzkovitz S, Noske A, Zurrer-Hardi U, Bell G, et al. 2012. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148: 1015-1028
29. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C,Weinberg RA, Lander ES. 2009. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138: 645-659
30. Hajra KM, Chen DY, Fearon ER. 2002. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 62: 1613-1618
31. Hong T,Watanabe K, Ta CH, Villarreal-Ponce A, Nie Q, Dai X. 2015. An Ovol2-Zeb1 mutual inhibitory circuit governs bidirectional and multi-step transition between epithelial and mesenchymal states. PLoS Comput Biol 11: e 1004569
32. Ikenouchi J, Matsuda M, Furuse M, Tsukita S. 2003. Regulation of tight junctions during the epithelium-mesenchyme transition: Direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci 116: 1959-1967
33. Jeanes A, Gottardi CJ, Yap AS. 2008. Cadherins and cancer: How does cadherin dysfunction promote tumor progression? Oncogene 27: 6920-6929
34. Jolly MK, Boareto M, Huang B, Jia D, Lu M, Ben-Jacob E, Onuchic JN, Levine H. 2015a. Implications of the hybrid epithelial/mesenchymal phenotype in metastasis. Front Oncol 5: 155
35. Jolly MK, Jia D, Boareto M, Mani SA, Pienta KJ, Ben-Jacob E, Levine H. 2015b. Coupling the modules of EMT and stemness: A tunable 'stemness window' model. Oncotarget 6: 25161-25174
36. Jorda M, Olmeda D, Vinyals A, Valero E, Cubillo E, Llorens A, Cano A, Fabra A. 2005. Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J Cell Sci 118: 3371-3385
37. Jordan NV, Johnson GL, Abell AN. 2011. Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer. Cell Cycle 10: 2865-2873
38. Kalluri R, Weinberg RA. 2009. The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428
39. Kelley LC, Lohmer LL, Hagedorn EJ, Sherwood DR. 2014. Traversing the basement membrane in vivo: A diversity of strategies. J Cell Biol 204: 291-302
40. Kessenbrock K, Plaks V, Werb Z. 2010. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 141: 52-67
41. Khalil AA, Friedl P. 2010. Determinants of leader cells in collective cell migration. Integr Biol (Camb) 2: 568-574
42. Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, Sarkar FH. 2010. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One 5: e 12445
43. Labelle M, Begum S, Hynes RO. 2011. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20: 576-590
44. Lee M, Vasioukhin V. 2008. Cell polarity and cancer-cell and tissue polarity as a non-canonical tumor suppressor. J Cell Sci 121: 1141-1150
45. Li W, Kang Y. 2016. Probing the fifty shades of EMT in metastasis. Trends Cancer 2: 65-67
46. Li HJ, Reinhardt F, Herschman HR, Weinberg RA. 2012. Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discov 2: 840-855
47. Li J, Liu J, Li P, Mao X, Li W, Yang J, Liu P. 2014. Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion. J Exp Clin Cancer Res 33: 70
48. + ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition. Oncotarget 6: 5846-5859
49. Lundgren K, Nordenskjold B, Landberg G. 2009. Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer. Br J Cancer 101: 1769-1781
50. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715
51. Martin TA, Jiang WG. 2009. Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta 1788: 872-891
52. Martin TA, Mansel RE, Jiang WG. 2010. Loss of occludin leads to the progression of human breast cancer. Int J Mol Med 26: 723-734
53. Martin-Belmonte F, Gassama A, Datta A, Yu W, Rescher U, Gerke V, Mostov K. 2007. PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell 128: 383-397
54. Martinez-Estrada OM, Culleres A, Soriano FX, Peinado H, Bolos V, Martinez FO, Reina M, Cano A, Fabre M, Vilaro S. 2006. The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells. Biochem J 394: 449-457
55. McCaffrey LM, Montalbano J, Mihai C, Macara IG. 2012. Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis. Cancer Cell 22: 601-614
56. Miyoshi A, Kitajima Y, Kido S, Shimonishi T, Matsuyama S, Kitahara K, Miyazaki K. 2005. Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma. Br J Cancer 92: 252-258
57. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. 2008. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3: e 2888
58. Munster PN, Troso-Sandoval T, Rosen N, Rifkind R, Marks PA, Richon VM. 2001. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. Cancer Res 61: 8492-8497
59. Nassour M, Idoux-Gillet Y, Selmi A, Come C, Faraldo ML, Deugnier MA, Savagner P. 2012. Slug controls stem/progen itor cell growth dynamics during mammary gland morphogenesis. PLoS One 7: e 53498
60. Nieto MA, Huang RY, Jackson RA, Thiery JP. 2016. EMT: 2016. Cell 166: 21-45
61. Ocana OH, Corcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S, Barrallo-Gimeno A, Cano A, Nieto MA. 2012. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22: 709-724
62. Ohkubo T, Ozawa M. 2004. The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. J Cell Sci 117: 1675-1685
63. Okada H, Danoff TM, Kalluri R, Neilson EG. 1997. Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 273: F563-F 574
64. Pattabiraman DR, Bierie B, Kober KI, Thiru P, Krall JA, Zill C, Reinhardt F, Tam WL, Weinberg RA. 2016. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science 351: aad 3680
65. Paulsson M. 1992. Basement membrane proteins: Structure, assembly, and cellular interactions. Crit Rev Biochem Mol Biol 27: 93-127
66. Rasheed ZA, Yang J, Wang Q, Kowalski J, Freed I, Murter C, Hong SM, Koorstra JB, Rajeshkumar NV, He X, et al. 2010. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J Natl Cancer Inst 102: 340-351
67. Revenu C, Gilmour D. 2009. EMT2.0: Shaping epithelia through collective migration. Curr Opin Genetics Dev 19: 338-342
68. Sampson VB, David JM, Puig I, Patil PU, de Herreros AG, Thomas GV, Rajasekaran AK. 2014. Wilms' tumor protein induces an epithelial-mesenchymal hybrid differentiation state in clear cell renal cell carcinoma. PLoS One 9: e 102041
69. Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, Bell G, GuoW, Rubin J, Richardson AL, et al. 2011. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145: 926-940
70. Schliekelman MJ, Taguchi A, Zhu J, Dai X, Rodriguez J, Celiktas M, Zhang Q, Chin A, Wong CH, Wang H, et al. 2015. Molecular portraits of epithelial, mesenchymal, and hybrid states in lung adenocarcinoma and their relevance to survival. Cancer Res 75: 1789-1800
71. Spaderna S, Schmalhofer O,Wahlbuhl M, Dimmler A, Bauer K, Sultan A, Hlubek F, Jung A, Strand D, Eger A, et al. 2008. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 68: 537-544
72. Takai E, Tan X, Tamori Y, Hirota M, Egami H, Ogawa M. 2005. Correlation of translocation of tight junction protein Zonula occludens-1 and activation of epidermal growth factor receptor in the regulation of invasion of pancreatic cancer cells. Int J Oncol 27: 645-651
73. Taki M, Verschueren K, Yokoyama K, Nagayama M, Kamata N. 2006. Involvement of Ets-1 transcription factor in inducing matrix metalloproteinase-2 expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Int J Oncol 28: 487-496
74. Tan TZ, Miow QH, Miki Y, Noda T, Mori S, Huang RY, Thiery JP. 2014. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO Mol Med 6: 1279-1293
75. Trimboli AJ, Fukino K, de Bruin A,Wei G, Shen L, Tanner SM, Creasap N, Rosol TJ, Robinson ML, Eng C, et al. 2008. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res 68: 937-945
76. Tsai JH, Yang J. 2013. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 27: 2192-2206
77. Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J. 2012. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22: 725-736
78. Uchida H, Maruyama T, Ono M, Ohta K, Kajitani T, Masuda H, Nagashima T, Arase T, Asada H, Yoshimura Y. 2007. Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up-regulation of glycodelin. Endocrinology 148: 896-902
79. Vleminckx K, Vakaet L Jr, Mareel M, FiersW, van Roy F. 1991. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107-119
80. Warrell RP Jr, de The H, Wang ZY, Degos L. 1993. Acute promyelocytic leukemia. N Engl J Med 329: 177-189
81. Westcott JM, Prechtl AM, Maine EA, Dang TT, Esparza MA, Sun H, Zhou Y, Xie Y, Pearson GW. 2015. An epigenetically distinct breast cancer cell subpopulation promotes collective invasion. J Clin Invest 125: 1927-1943
82. Whiteman EL, Liu CJ, Fearon ER, Margolis B. 2008. The transcription factor snail represses Crumbs3 expression and disrupts apico-basal polarity complexes. Oncogene 27: 3875-3879
83. Xie G, Ji A, Yuan Q, Jin Z, Yuan Y, Ren C, Guo Z, Yao Q, Yang K, Lin X, et al. 2014. Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines. Br J Cancer 110: 2514-2523
84. Xu WS, Parmigiani RB, Marks PA. 2007. Histone deacetylase inhibitors: Molecular mechanisms of action. Oncogene 26: 5541-5552
85. Yamamoto M, Taguchi Y, Ito-Kureha T, Semba K, Yamaguchi N, Inoue J. 2013. NF-kB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype. Nat Commun 4: 2299
86. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. 2004. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939
87. Ye X, Tam WL, Shibue T, Kaygusuz Y, Reinhardt F, Ng Eaton E, Weinberg RA. 2015. Distinct EMT programs control normal mammary stem cells and tumour-initiating cells. Nature 525: 256-260
88. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, et al. 2013. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339: 580-584
89. Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, Wu CC, LeBleu VS, Kalluri R. 2015. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527: 525-530
90. Zhou D, Kannappan V, Chen X, Li J, Leng X, Zhang J, Xuan S. 2016. RBP2 induces stem-like cancer cells by promoting EMT and is a prognostic marker for renal cell carcinoma. Exp Mol Med 48: e 238